voriconazole
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 43/100
43
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Infections, Fungal
Conditions
Infections, Fungal
Trial Timeline
Mar 1, 2007 → Aug 1, 2008
NCT ID
NCT00300677About voriconazole
voriconazole is a approved stage product being developed by Pfizer for Infections, Fungal. The current trial status is completed. This product is registered under clinical trial identifier NCT00300677. Target conditions include Infections, Fungal.
What happened to similar drugs?
20 of 20 similar drugs in Infections, Fungal were approved
Approved (20) Terminated (3) Active (0)
Hype Score Breakdown
Clinical
20
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (15)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01092832 | Phase 3 | Terminated |
| NCT00836875 | Phase 3 | Terminated |
| NCT00855101 | Phase 1 | Completed |
| NCT00721578 | Pre-clinical | Completed |
| NCT00556998 | Phase 2 | Completed |
| NCT00455364 | Approved | Terminated |
| NCT00300677 | Approved | Completed |
| NCT01660334 | Pre-clinical | Completed |
| NCT01151085 | Pre-clinical | Completed |
| NCT00288197 | Approved | Completed |
| NCT00159822 | Phase 2/3 | Completed |
| NCT00136968 | Phase 1 | Completed |
| NCT00143312 | Approved | Completed |
| NCT00174473 | Phase 1/2 | Completed |
| NCT00647907 | Approved | Completed |
Competing Products
20 competing products in Infections, Fungal